Genetic engineering a large animal model of human hypophosphatasia in sheep
暂无分享,去创建一个
L. Suva | D. Gaddy | C. Long | J. Pryor | B. Foster | Michael B Chavez | S. Huggins | M. Westhusin | Alyssa R Falck | S. White | D. Williams | C. Pinzón | Forrest Herman | James Oldeschulte
[1] Xiaolong Wang,et al. Efficient generation of goats with defined point mutation (I397V) in GDF9 through CRISPR/Cas9. , 2018, Reproduction, fertility, and development.
[2] Xiaoying Fan,et al. Multiplexed sgRNA Expression Allows Versatile Single Nonrepetitive DNA Labeling and Endogenous Gene Regulation. , 2017, ACS synthetic biology.
[3] E. Mornet. Genetics of hypophosphatasia. , 2017, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie.
[4] R. Hu,et al. RAPID COMMUNICATION: Generation of FGF5 knockout sheep via the CRISPR/Cas9 system. , 2017, Journal of animal science.
[5] M. Whyte. Hypophosphatasia: Enzyme Replacement Therapy Brings New Opportunities and New Challenges , 2017, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[6] D. Wenkert,et al. Hypophosphatasia: Natural history study of 101 affected children investigated at one research center. , 2016, Bone.
[7] Martin Picard,et al. The Spectrum of Mitochondrial Ultrastructural Defects in Mitochondrial Myopathy , 2016, Scientific Reports.
[8] T. Odrljin,et al. Asfotase alfa therapy for children with hypophosphatasia. , 2016, JCI insight.
[9] S. Mumm,et al. ADULT HYPOPHOSPHATASIA TREATED WITH TERIPARATIDE: REPORT OF 2 PATIENTS AND REVIEW OF THE LITERATURE. , 2016, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[10] M. Whyte. Hypophosphatasia — aetiology, nosology, pathogenesis, diagnosis and treatment , 2016, Nature Reviews Endocrinology.
[11] N. Bishop,et al. Asfotase Alfa Treatment Improves Survival for Perinatal and Infantile Hypophosphatasia. , 2016, The Journal of clinical endocrinology and metabolism.
[12] J. Millán,et al. Alkaline Phosphatase and Hypophosphatasia , 2015, Calcified Tissue International.
[13] L. Tesson,et al. Efficient Generation of Myostatin Knock-Out Sheep Using CRISPR/Cas9 Technology and Microinjection into Zygotes , 2015, PloS one.
[14] R. Sah,et al. Periodontal Defects in the A116T Knock-in Murine Model of Odontohypophosphatasia , 2015, Journal of dental research.
[15] G. Berkovitz,et al. Childhood hypophosphatasia with homozygous mutation of ALPL. , 2014, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[16] G. Niebur,et al. Alterations in trabecular bone microarchitecture in the ovine spine and distal femur following ovariectomy. , 2014, Journal of biomechanics.
[17] M. Somerman,et al. Rare Bone Diseases and Their Dental, Oral, and Craniofacial Manifestations , 2014, Journal of dental research.
[18] J. Millán,et al. Enzyme replacement prevents enamel defects in hypophosphatasia mice , 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[19] B. Faircloth,et al. Primer3—new capabilities and interfaces , 2012, Nucleic acids research.
[20] Nick Bishop,et al. Enzyme-replacement therapy in life-threatening hypophosphatasia. , 2012, The New England journal of medicine.
[21] Jeffrey J. Gray,et al. Enzyme Replacement Therapy Prevents Dental Defects in a Model of Hypophosphatasia , 2011, Journal of dental research.
[22] V. Bowles,et al. Biomedical applications of sheep models: from asthma to vaccines. , 2008, Trends in biotechnology.
[23] T. Pierson,et al. Inhibin A is an endocrine stimulator of bone mass and strength. , 2007, Endocrinology.
[24] Maido Remm,et al. Enhancements and modifications of primer design program Primer3 , 2007, Bioinform..
[25] S. Mumm,et al. Low serum alkaline phosphatase activity and pathologic fracture: case report and brief review of hypophosphatasia diagnosed in adulthood. , 2006, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[26] S. Mumm,et al. Homozygosity for TNSALP mutation 1348c>T (Arg433Cys) causes infantile hypophosphatasia manifesting transient disease correction and variably lethal outcome in a kindred of black ancestry. , 2006, The Journal of pediatrics.
[27] A. M. Parfitt,et al. The cellular basis of bone remodeling: The quantum concept reexamined in light of recent advances in the cell biology of bone , 2006, Calcified Tissue International.
[28] J. L. Vance,et al. Long‐term ovariectomy decreases ovine compact bone viscoelasticity , 2005, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[29] J. L. Vance,et al. Determinants of ovine compact bone viscoelastic properties: effects of architecture, mineralization, and remodeling. , 2004, Bone.
[30] Michael Zuker,et al. Mfold web server for nucleic acid folding and hybridization prediction , 2003, Nucleic Acids Res..
[31] A. Turner,et al. The sheep as a model for osteoporosis in humans. , 2002, Veterinary journal.
[32] C. Loopstra,et al. Sequences upstream and downstream of two xylem-specific pine genes influence their expression. , 2000, Plant science : an international journal of experimental plant biology.
[33] J. Millán,et al. Alkaline Phosphatase Knock‐Out Mice Recapitulate the Metabolic and Skeletal Defects of Infantile Hypophosphatasia , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[34] J. Sulon,et al. Early pregnancy diagnosis in goats by determination of pregnancy-associated glycoprotein concentrations in plasma samples. , 1999, Theriogenology.
[35] P. Delmas,et al. The anabolic effect of human PTH (1-34) on bone formation is blunted when bone resorption is inhibited by the bisphosphonate tiludronate--is activated resorption a prerequisite for the in vivo effect of PTH on formation in a remodeling system? , 1995, Bone.
[36] J. Wark,et al. The potential of sheep for the study of osteopenia: current status and comparison with other animal models. , 1995, Bone.
[37] P. Delmas,et al. Osteopenia and bone‐remodeling abnormalities in warfarin‐treated lambs , 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[38] P. Delmas,et al. Dose effects on ewe bone remodeling of short-term sodium fluoride administration--a histomorphometric and biochemical study. , 1991, Bone.
[39] P. Delmas,et al. Biochemical markers of bone turnover for the clinical assessment of metabolic bone disease. , 1990, Endocrinology and metabolism clinics of North America.
[40] M. Whyte. Heritable metabolic and dysplastic bone diseases. , 1990, Endocrinology and metabolism clinics of North America.
[41] Y. Sharav,et al. Tooth development in sheep. , 1964, The Dental magazine and oral topics.